Norbert Bischofberger - Jun 6, 2025 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
Stock symbol
VIR
Transactions as of
Jun 6, 2025
Transactions value $
$0
Form type
4
Date filed
6/6/2025, 08:26 PM
Previous filing
Jun 2, 2025
Next filing
Jun 20, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BISCHOFBERGER NORBERT W Director C/O VIR BIOTECHNOLOGY, INC., 1800 OWENS STREET, SUITE 900, SAN FRANCISCO /s/ Vanina de Verneuil, Attorney-In-Fact 2025-06-06 0001190273

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Other $0 -10.7K -44.45% $0.00 13.3K Jun 6, 2025 Direct F1
transaction VIR Common Stock Other $0 +10.7K $0.00 10.7K Jun 6, 2025 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transfer without consideration for tax planning purposes.
F2 The shares are held in the name of Nextquest, LLC, of which the Reporting Person is a managing member.